Hsieh Nan K, Wang Jia Y, Liu Jiang C, Lee Wei H, Chen Hsing I
Graduate Institute of Medical Sciences, National Defense Medical Center, National Defense University, Taipei, Taiwan.
Thromb Haemost. 2004 Jul;92(1):162-70. doi: 10.1160/TH03-10-0610.
Chronic inhibition of nitric oxide (NO) synthesis with N(omega)-nitro-L-arginine methyl ester (L-NAME) has become a model of hypertension. The purpose of this study was to evaluate the morphological changes of cerebral arteries in rats with genetic hypertension and hypertension induced by chronic NO deprivation. Spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto strain (WKY) were given L-NAME (1 mg.ml(-1)) from age 5 to 7 or 9 weeks. We assessed vascular remodelling and arteriolar injury score (AIS) in various cerebral arteries using different immunohistochemical staining techniques. In WKY and SHR, L-NAME caused an elevation in tail cuff pressure (TCP). The increase in TCP was larger in SHR than in WKY. L-NAME decreased body weight, but increased heart weight in SHR. The lumen diameter and media cross-section area of internal carotid artery (ICA) in SHR were smaller than those in WKY, and further reduced in SHR and WKY after L-NAME treatment. These findings indicate that cerebral vascular remodelling occurs following chronic hypertension either from genetic origin or NO deprivation. L-NAME increased the media thickness in SHR, but not in WKY. This agent also caused an increase in cell volume density, AIS, and inflammatory cells infiltration in perivascular space with a negative growth index in ICA. The media/lumen ratio was higher in SHR than WKY, and further increased following L-NAME treatment. Diversified vascular remodelling occurred in hypertensive rats, but not in untreated WKY. In summary, these results suggest that NO deprivation and genetic hypertension cause vascular changes in various cerebral arteries.
用N(ω)-硝基-L-精氨酸甲酯(L-NAME)慢性抑制一氧化氮(NO)合成已成为高血压模型。本研究的目的是评估遗传性高血压大鼠和慢性NO缺乏诱导的高血压大鼠脑动脉的形态学变化。自发性高血压大鼠(SHR)和血压正常的Wistar-Kyoto品系(WKY)从5至7周龄或9周龄开始给予L-NAME(1mg·ml⁻¹)。我们使用不同的免疫组织化学染色技术评估了各种脑动脉的血管重塑和小动脉损伤评分(AIS)。在WKY和SHR中,L-NAME导致尾袖带压力(TCP)升高。SHR中TCP的升高幅度大于WKY。L-NAME降低了SHR的体重,但增加了其心脏重量。SHR颈内动脉(ICA)的管腔直径和中膜横截面积小于WKY,L-NAME处理后SHR和WKY的上述指标进一步降低。这些发现表明,无论是遗传性高血压还是NO缺乏导致的慢性高血压后都会发生脑血管重塑。L-NAME增加了SHR的中膜厚度,但未增加WKY的中膜厚度。该药物还导致ICA中细胞体积密度、AIS增加,血管周围间隙有炎性细胞浸润且生长指数为负。SHR的中膜/管腔比值高于WKY,L-NAME处理后进一步增加。高血压大鼠发生了多样化的血管重塑,但未处理的WKY未发生。总之,这些结果表明,NO缺乏和遗传性高血压会导致各种脑动脉发生血管变化。